Otonomy Suspends Development of Lead Drug After Phase III Flop, Stock Plunges Post author:Sam Post published:August 29, 2017 Post category:BioPharma August 30, 2017By Alex Keown, BioSpace… Source: BioSpace You Might Also Like Indiana University School of Medicine Awarded Prestigious $2.1 Million Grant To Study Traumatic Brain Injury October 1, 2017 Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017 LifeNet to Create Hundred of New Jobs in Virginia Through HQ Expansion August 17, 2017
Indiana University School of Medicine Awarded Prestigious $2.1 Million Grant To Study Traumatic Brain Injury October 1, 2017
Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017
